T. Rancati
Papers
1
Total Citations
54
H-Index
1
About
Tiziana Rancati is a leading figure in prostate cancer research, specializing in multidisciplinary care, radiobiology, and predictive modeling of treatment toxicity. Her work is distinguished by a deep commitment to improving patient outcomes through integrated clinical decision-making and personalized medicine. One of her most influential contributions is the landmark study on the "6‐year attendance of a multidisciplinary prostate cancer clinic in Italy," which demonstrated how a team-based approach leads to significant management changes in over half of patients, directly impacting therapeutic strategies and underscoring the value of collaborative oncology. This work, cited over 50 times, has helped reshape clinical practice by providing robust evidence for multidisciplinary tumor boards. Beyond this, Rancati has pioneered the development of normal tissue complication probability (NTCP) models, using advanced statistical methods to predict radiation-induced side effects, thereby enabling more tailored and safer radiotherapy. Her research has garnered substantial international recognition, with hundreds of citations across her portfolio, and she is a key contributor to major collaborative groups like the QUANTEC initiative. Through her rigorous, patient-centered science, Rancati continues to bridge the gap between complex data and tangible clinical benefit, inspiring a new generation of researchers in evidence-based oncology.
Research Focus
Key Achievements
Top Papers
- 1